Information  X 
Enter a valid email address

Westminster Group (WSG)

  Print          Annual reports

Wednesday 03 June, 2020

Westminster Group

Fever Screening Trials at Stockholm Airport

RNS Number : 7369O
Westminster Group PLC
03 June 2020
 

 

Westminster Group Plc

('Westminster', the 'Group' or the 'Company')

Fever Screening Trials at Stockholm Arlanda Airport

 

 

Westminster Group Plc (AIM: WSG), a leading supplier of managed services and technology-based security solutions worldwide, is pleased to announce that it has conducted a successful trial of its fever screening solutions in association with Menzies Aviation and their client, Air France, at Stockholm Arlanda Airport.

 

Using the Westminster fever screening solution, Menzies Aviation will continue to conduct operational trials with Air France and other clients' flights' over the coming weeks in order to fine tune an effective delivery to this added layer of safety and security. Feedback from the first live trial was extremely positive with all passengers screened as they presented their boarding passes at the departure gate. The trial at Stockholm Arlanda Airport is Westminster's first trial at a Scandinavian airport as it looks to widen its client database and airport presence.

 

Commenting on the trial Westminster's General Manager, Hamish Russell, said:

 

"Working with Menzies Aviation on the trial has been excellent. We have worked hard in order to supply them with the correct solution for their fever screening requirements that is fit for purpose and has the least impact on an already complex procedure, and within the required time frame. I need to thank all those involved at Menzies Aviation both in the UK and their team in Sweden for their efforts.

 

"Westminster's fever screening solutions have been supplied to numerous industry sectors to detect, mitigate and defeat the spread of COVID-19. Westminster continues to add to its fever screening offering ensuring products are adaptable, cost effective and can be implemented and upgraded into existing processes or technology."

 

For further information on Westminster's Fever Screening Equipment and other products please click https://www.wi-ltd.com  

 

 

 

For further information please contact:

 

Westminster Group Plc

Media enquiries via Walbrook PR

Rt. Hon. Sir Tony Baldry - Chairman

 

Peter Fowler - Chief Executive Officer

 

Mark Hughes - Chief Financial Officer

 

 

 

S. P. Angel Corporate Finance LLP (NOMAD & Broker)

 

Stuart Gledhill

020 3470 0470

Caroline Rowe

 

 

 

Walbrook (Investor Relations)

 

Tom Cooper

020 7933 8780

Paul Vann

 

Nick Rome

[email protected]

 

 

Notes:

 

Westminster Group plc is a specialist security and services group operating worldwide via an extensive international network of agents and offices in over 50 countries.

 

Westminster's principal activity is the design, supply and ongoing support of advanced technology security solutions, encompassing a wide range of surveillance, detection (including Fever Detection), tracking and interception technologies and the provision of long-term managed services contracts such as the management and running of complete security services and solutions in airports, ports and other such facilities together with the provision of manpower, consultancy and training services. The majority of its customer base, by value, comprises governments and government agencies, non-governmental organisations (NGO's) and blue-chip commercial organisations.

 

The Westminster Group Foundation was formed in 2014 as an initiative of Westminster Group plc. during the West African Ebola Crisis.

 

The Foundation's goal is to support the communities in which the Group operates by working with local partners and other established charities to provide goods or services for the relief of poverty and the advancement of education and healthcare particularly in the developing world.

 

The Westminster Group Foundation is a Charitable Incorporated Organisation, CIO, registered with the Charities Commission number 1158653.

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NRAFTMFTMTBMBFM

a d v e r t i s e m e n t